1350 related articles for article (PubMed ID: 17949555)
1. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
2. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
[TBL] [Abstract][Full Text] [Related]
3. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
4. Serum leptin levels in patients with ocular and nonocular Behçet's disease.
Yalçindağ FN; Kisa U; Batioğlu F; Yalçindağ A; Ozdemir O; Cağlayan O
Mediators Inflamm; 2007; 2007():31986. PubMed ID: 17641728
[TBL] [Abstract][Full Text] [Related]
5. Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.
Yuksel M; Yildiz A; Oylumlu M; Turkcu FM; Bilik MZ; Ekinci A; Elbey B; Tekbas E; Alan S
Clin Rheumatol; 2016 Mar; 35(3):701-8. PubMed ID: 25744156
[TBL] [Abstract][Full Text] [Related]
6. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
[TBL] [Abstract][Full Text] [Related]
7. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
Keskin D; Keskin G; Inal A; Ozışık L
Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
[TBL] [Abstract][Full Text] [Related]
8. The determination of matrix metalloproteinase 9 activity and gene expression levels in Behcet's disease patients with aneurysmal complications.
Aksoy Y; Ercan A; Dalmizrak O; Canpinar H; Kartal Durmazlar SP; Bayazit M
Clin Rheumatol; 2011 Apr; 30(4):515-9. PubMed ID: 20842516
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
[TBL] [Abstract][Full Text] [Related]
10. Association of MMP-9 gene polymorphisms with Behçet's disease risk.
Naouali A; Kaabachi W; Tizaoui K; Amor AB; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Mar; 164(1):18-24. PubMed ID: 25639450
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
12. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM
Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
[TBL] [Abstract][Full Text] [Related]
13. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity.
Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?
Musabak U; Pay S; Erdem H; Simsek I; Pekel A; Dinc A; Sengul A
Rheumatol Int; 2006 Apr; 26(6):545-50. PubMed ID: 16205927
[TBL] [Abstract][Full Text] [Related]
15. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O
Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
[TBL] [Abstract][Full Text] [Related]
16. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement.
Yalçindağ FN; Batioğlu F; Ozdemir O; Cansizoğlu E; Eğin Y; Akar N
Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1603-8. PubMed ID: 18604550
[TBL] [Abstract][Full Text] [Related]
17. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease.
Sertoglu E; Omma A; Yucel C; Colak S; Sandıkcı SC; Ozgurtas T
Scand J Clin Lab Invest; 2018 Oct; 78(6):443-449. PubMed ID: 30015524
[TBL] [Abstract][Full Text] [Related]
18. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
19. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
[TBL] [Abstract][Full Text] [Related]
20. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease.
Er H; Evereklioglu C; Cumurcu T; Türköz Y; Ozerol E; Sahin K; Doganay S
Br J Ophthalmol; 2002 Jun; 86(6):653-7. PubMed ID: 12034688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]